Investors

Insider Transactions

Date Name Sorted Descending Title Type Shares Traded Price Range
Mar 12, 2014 sanofi Beneficial Owner (10% or more) Buy 220,995 325.40 - 339.27
Mar 11, 2014 sanofi Beneficial Owner (10% or more) Buy 180,710 328.82 - 335.68
Mar 10, 2014 sanofi Beneficial Owner (10% or more) Buy 199,822 325.34 - 332.26
Mar 7, 2014 sanofi Beneficial Owner (10% or more) Buy 241,818 327.77 - 339.06
Mar 7, 2014 sanofi Beneficial Owner (10% or more) Buy 69,873 304.21 - 325.82
Mar 6, 2014 sanofi Beneficial Owner (10% or more) Buy 80,404 338.64 - 339.82
Mar 3, 2014 sanofi Beneficial Owner (10% or more) Buy 251,594 328.00 - 339.94
Feb 7, 2014 sanofi Beneficial Owner (10% or more) Buy 21,986 284.49 - 289.98
Feb 6, 2014 sanofi Beneficial Owner (10% or more) Buy 146,525 282.84 - 287.88
Feb 5, 2014 sanofi Beneficial Owner (10% or more) Buy 206,978 274.64 - 288.13
Feb 4, 2014 sanofi Beneficial Owner (10% or more) Buy 190,286 282.05 - 287.78
Feb 3, 2014 sanofi Beneficial Owner (10% or more) Buy 198,058 279.14 - 289.62
Jan 31, 2014 sanofi Beneficial Owner (10% or more) Buy 10,914 286.13 - 289.90
Jan 28, 2014 sanofi Beneficial Owner (10% or more) Buy 83,235 273.44 - 279.26
Jan 27, 2014 sanofi Beneficial Owner (10% or more) Buy 74,685 269.77 - 275.31
Oct 13, 2010 sanofi Beneficial Owner (10% or more) Buy 1,017,401 28.00
Dec 20, 2007 sanofi Beneficial Owner (10% or more) Statement of Ownership 0 n/a
Aug 23, 2013 ryan arthur f Director Sell 10,958 238.47
Aug 22, 2013 ryan arthur f Director Option Execute 30,000 18.61 - 57.11
Aug 22, 2013 ryan arthur f Director Disposition (Non Open Market) 4,042 236.64
Showing 301-320 of 773 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)